Metagenomics Market 2027 By Product, Distribution Channel, Technology, Key Manufacturers | The Insight Partners

Metagenomics Market to 2027 - Global Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Geography

Publication Month: Jan 2019 | Report Code: TIPRE00002997 | No. of Pages: 139 | Category: Biotechnology | Status: Published

The global metagenomics market is expected to reach US$ 314.3 Mn in 2027 from US$ 165.8 in 2018. The market is estimated to grow with a CAGR of 7.7% from 2018-2027.

Metagenomics market is segmented by product, application, and geography. Global metagenomics market, based on the product was segmented into instruments and software and consumables.

Metagenomics can be defined as the study of the metagenome, which is collective genome of microorganisms. The microorganisms are collected from an environmental samples and the studies are conducted to provide information on the microbial diversity and ecology of a specific environment. The study of microorganism is conducted through the shotgun metagenomics technology/ technique which is used to extract the DNA from the environmental sample and sequence the small fragments. The metagenomic is the rising and vibrant field that has appropriated the tools used for standard genomics and applied for the study of the entire communities of microbes. This requires no need to isolate and culture the individual microbial species. The primary aim of the metagenomics is study and identify the genes and metabolic pathways present in the microbial species. The report would be of an interest to various stakeholders operating in the metagenomics market. These stakeholders include metagenomics manufacturers, vendors, and distributors, research institutes and government organizations, venture capitalists and other government funding organizations, research and consulting firms, healthcare institutions and others.

The objective of the study is to describe, define, and forecast the metagenomics market by type and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

The report analyzes factors affecting metagenomics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key metagenomics manufacturing companies along with their SWOT analysis and market strategies.

The major players operating in the metagenomics market include Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies, Qiagen, Bio-Rad Laboratories, Inc., Perkinelmer Inc., and Illumina Inc., f Hoffman-La Roche Ltd., Oxford Nanopore Technologies Ltd., Pacific Bioscience of California, Inc. among others. The market players are incorporating organic growth strategies such as introduction of new products into the market to sustain their global position in the highly competitive global metagenomics market. For instance, in August 2018, Agilent Technologies Inc. announced launch of the new version of its chromatography data system that will help to export lab files in the Allotrope Data Format (ADF), an emerging standard developed by a consortium of pharmaceutical companies.








 

TABLE OF CONTENTS

1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. GLOBAL METAGENOMICS MARKET – KEY TAKEAWAYS

3. GLOBAL METAGENOMICS MARKET – MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 Global Metagenomics Market – By Product
3.2.2 Global Metagenomics Market – By Application
3.2.3 Global Metagenomics Market – By Geography
3.3 PEST ANALYSIS
3.3.1 North America – PEST Analysis
3.3.2 Europe– PEST Analysis
3.3.3 Asia Pacific– PEST Analysis
3.3.4 Middle East And Africa– PEST Analysis
3.3.5 South and Central America – PEST Analysis

4. GLOBAL METAGENOMICS MARKET – KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Increasing Venture Capital Investments
4.1.2 Advantages of Metagenomics in Biotechnology
4.1.3 Industrial Applications of Metagenomics
4.2 KEY MARKET RESTRAINTS
4.2.1 High Capital Costs Of Metagenomics
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Usage of Metagenomics for Precision Medicine
4.3.2 Emerging Nations
4.4 KEY MARKET TRENDS
4.4.1 Extensive Set Of Molecular-Based Approaches
4.5 IMPACT ANALYSIS

5. METAGENOMICS MARKET – GLOBAL ANALYSIS
5.1 GLOBAL METAGENOMICS MARKET REVENUE FORECASTS AND ANALYSIS
5.2 GLOBAL METAGENOMICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
5.3 MARKET POSITIONING
5.4 PERFORMANCE OF KEY PLAYERS
5.4.1 Illumina, Inc.
5.4.2 Qiagen
5.5 EXPERT OPINIONS

6. GLOBAL METAGENOMICS MARKET ANALYSIS – BY PRODUCT
6.1 OVERVIEW
6.2 GLOBAL METAGENOMICS MARKET, BY PRODUCT, 2018 & 2027 (%)
6.3 INSTRUMENTS & SOFTWARE MARKET
6.3.1 Overview
6.3.2 Global Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 CONSUMABLES MARKET
6.4.1 Overview
6.4.2 Global Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

7. GLOBAL METAGENOMICS MARKET ANALYSIS – BY APPLICATION
7.1 OVERVIEW
7.2 GLOBAL METAGENOMICS MARKET, BY APPLICATION, 2018 & 2027 (%)
7.3 CLINICAL DIAGNOSTIC MARKET
7.3.1 Overview
7.3.2 Global Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 DRUG DISCOVERY METAGENOMICS MARKET
7.4.1 Overview
7.4.2 Global Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 OTHERS MARKET
7.5.1 Overview
7.5.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
8.1 OVERVIEW
8.2 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.3 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
8.4 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
8.5 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
8.6 US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.1 US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.2 US Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.6.3 US Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.7 CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.7.1 Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.2 Canada Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.7.3 Canada Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.8 MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.1 Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.2 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.8.3 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
9.1 OVERVIEW
9.2 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.3 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
9.4 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
9.5 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
9.6 UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.6.1 UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
9.6.2 UK Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.6.3 UK Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.7 GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.7.1 Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
9.7.2 Germany Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.7.3 Germany Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.8 FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9.8.1 France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
9.8.2 France Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.8.3 France Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 70
10.1 OVERVIEW
10.2 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.3 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
10.4 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
10.5 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
10.6 CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.6.1 China Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
10.6.2 China Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.6.3 China Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.7 JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.7.1 Japan Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
10.7.2 Japan Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.7.3 Japan Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.8 INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.8.1 India Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.2 India Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.8.3 India Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

11. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
11.1 OVERVIEW
11.2 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.3 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
11.4 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
11.5 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
11.6 UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.6.1 UAE Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.2 UAE Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.6.3 UAE Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.7 SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.7.1 Saudi Arabia Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.7.2 Saudi Arabia Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.7.3 Saudi Arabia Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.8 SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.8.1 South Africa Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
11.8.2 South Africa Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.8.3 South Africa Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

12. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027
12.1 OVERVIEW
12.2 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
12.3 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
12.4 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
12.5 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
12.6 BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
12.6.1 Brazil Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
12.6.2 Brazil Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
12.6.3 Brazil Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

13. METAGENOMICS MARKET –INDUSTRY LANDSCAPE
13.1 OVERVIEW
13.2 GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
13.3 ORGANIC DEVELOPMENTS
13.3.1 Overview
13.4 ORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
13.5 PRODUCT LAUNCH
13.5.1 Recent Product Launch By Players In The Metagenomics Market
13.6 PRODUCT APPROVAL
13.6.1 Recent Product Approval By Players In The Metagenomics Market
13.7 EXPANSION & OTHERS
13.7.1 The Metagenomics Market By Expansion & Other Growth Strategies
13.8 INORGANIC DEVELOPMENTS
13.8.1 Overview
13.9 INORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
13.10 ACQUISITIONS
13.10.1 Acquisitions By Players In The Metagenomics Market
13.11 AGREEMENTS
13.11.1 The Metagenomics Market By Agreements
13.12 PARTNERSHIP & COLLABORATION
13.12.1 Partnership By Players In The Metagenomics Market

14. METAGENOMICS MARKET–KEY COMPANY PROFILES
14.1 MERCK KGAA
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 THERMO FISHER SCIENTIFIC, INC.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Information
14.2.4 Product Portfolio
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 AGILENT TECHNOLOGIES, INC.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 QIAGEN
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 Product Portfolio
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES, INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Information
14.5.4 Product Portfolio
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 PERKIN ELMER, INC.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Overview
14.6.4 Product Portfolio
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 ILLUMINA, INC.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 F. HOFFMANN-LA ROCHE LTD.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Overview
14.8.4 Product Portfolio
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 OXFORD NANOPORE TECHNOLOGIES LTD.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 Product & Services Portfolio
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 PACIFIC BIOSCIENCE OF CALIFORNIA, INC.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Overview
14.10.4 Product & Services Portfolio
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 ABOUT THE INSIGHT PARTNERS
15.2 GLOSSARY OF TERMS
15.3 METHODOLOGY
15.3.1 Coverage
15.3.2 Secondary Research
15.3.3 Primary Research

LIST OF TABLES

TABLE 1. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 2. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 3. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 4. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 5. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 6. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 7. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 8. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 9. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 10. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 11. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 12. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 13. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 14. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 15. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 16. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 17. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 18. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 19. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 20. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 21. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 22. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 23. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 24. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 25. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 26. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 27. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 28. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 29. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 30. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 31. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 32. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 33. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 34. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 35. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 36. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 37. RECENT PRODUCT LAUNCH IN THE METAGENOMICS MARKET
TABLE 38. RECENT PRODUCT APPROVAL AND ENHANCEMENTS IN THE METAGENOMICS MARKET
TABLE 39. THE METAGENOMICS MARKET BY EXANSION & OTHERS STRATEGIES
TABLE 40. ACQUISITIONS IN THE METAGENOMICS MARKET
TABLE 41. THE METAGENOMICS MARKET BY AGREEMENTS
TABLE 42. PARTNERSHIP IN THE METAGENOMICS MARKET
TABLE 43. GLOSSARY OF TERMS, METAGENOMICS MARKET

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC METAGENOMICS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027
FIGURE 2. GLOBAL METAGENOMICS MARKET BY PRODUCT, MARKET SHARE (%), 2018
FIGURE 3. GLOBAL METAGENOMICS MARKET BY APPLICATION, MARKET SHARE (%), 2018
FIGURE 4. METAGENOMICS MARKET SEGMENTATION
FIGURE 5. METAGENOMICS SEGMENTATION, BY REGION
FIGURE 6. NORTH AMERICA PEST ANALYSIS
FIGURE 7. EUROPE PEST ANALYSIS
FIGURE 8. ASIA PACIFIC PEST ANALYSIS
FIGURE 9. MIDDLE EAST AND AFRICA PEST ANALYSIS
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS
FIGURE 11. METAGENOMICS MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
FIGURE 12. GLOBAL METAGENOMICS MARKET – REVENUE FORECASTS AND ANALYSIS – 2018- 2027
FIGURE 13. GLOBAL METAGENOMICS MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2018- 2027
FIGURE 14. GLOBAL METAGENOMICS MARKET BY PRODUCT, 2018 & 2027 (%)
FIGURE 15. GLOBAL INSTRUMENTS & SOFTWARE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 16. GLOBAL CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. GLOBAL METAGENOMICS MARKET BY APPLICATION, 2018 & 2027 (%)
FIGURE 18. GLOBAL CLINICAL DIAGNOSTIC MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. GLOBAL DRUG DISCOVERY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 20. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 21. NORTH AMERICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 22. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 23. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 24. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 26. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 27. EUROPE METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 28. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 29. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 30. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 31. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 32. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 33. ASIA PACIFIC METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 34. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 35. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 36. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 37. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 38. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 39. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 40. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 41. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 42. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 43. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 44. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 45. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 46. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 47. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 48. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 49. GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
FIGURE 50. ORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018
FIGURE 51. INORGANIC DEVELOPMENTS IN THE METAGENOMICS MARKET, 2015-2018

The List of Companies

1. Merck KGaA
2. Thermo Fisher Scientific Inc.
3. Agilent Technologies
4. Qiagen
5. Bio-Rad Laboratories, Inc.
6. Perkinelmer Inc.
7. Illumina Inc.
8. F Hoffman-La Roche Ltd.
9. Oxford Nanopore Technologies Ltd.
10. Pacific Bioscience of California, Inc.
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the metagenomics market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global metagenomics market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550